Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.67
May. 06, 2026 10:57:46- Change -0.0002 (-0.03002552%)
- Volume 23,504
- Today's Open 0.6703
- Previous Close 0.6661
- Today's High 0.6703
- Today's Low 0.65
- 52 Week High 1.96
- 52 Week Low 0.281